Michel Roger

Dr. Michel Roger


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2011 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
BBBluma G. Brenner
Bluma G. Brenner
MLMatthew Lowe
Matthew Lowe
DMDaniela Moisi
Daniela Moisi
IHIsabelle Hardy
Isabelle Hardy
SGSimon Gagnon
Simon Gagnon
MRMichel Roger
Michel Roger

15 January 2006 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JLJulie Lajoie
Julie Lajoie
JHJohn Hargrove
John Hargrove
LZLynn S. Zijenah
Lynn S. Zijenah
JHJean H. Humphrey
Jean H. Humphrey
BWBrian J. Ward
Brian J. Ward
MRMichel Roger
Michel Roger
Human leukocyte antigen (HLA)–E and HLA-G molecules act as powerful modulators of the innate immune response. The present study shows that the HLA-EG

18 November 2011 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
RFRhea Ferguson
Rhea Ferguson
ARAgnihotram V. Ramanakumar
Agnihotram V. Ramanakumar
AKAnita Koushik
Anita Koushik
FCFrançois Coutlée
François Coutlée
EFEduardo Franco
Eduardo Franco
TTthe Biomarkers of Cervical Cancer Risk Study Team
the Biomarkers of Cervical Cancer Risk Study Team
Human leukocyte antigen (HLA)‐G acts as negative regulator of the immune responses and its expression in tumor cells may enable them to escape immunosurveillance. The purpose of this study was to investigate the influence of HLA‐G polymorphism on risk of high‐grade cervical intraepithelial neoplasia (HG‐CIN) and cervical cancer in a Canadian population. The authors have analyzed 1,372 women from participants recruited between 2001 and 2009 in the ongoing Biomarkers of Cervical Cancer Risk case–control study. A total of 539 women with histologically confirmed HG‐CIN and invasive cancer formed the case series, and 833 women with normal cytology served as controls. Cervical specimens were tested for human papillomavirus (HPV) DNA using the MY09/11 PCR protocol and HLA‐G alleles where determined using a direct DNA sequencing procedures. HLA‐G polymorphisms were not associated with HG‐CIN or HPV infection. However, the risk for invasive cancer was significantly increased with the homozygous genotypes HLA‐G*01:01:02 [odds ratio (OR) = 3.52, 95% confidence interval (CI): 1.43–8.61, p = 0.006], −G*01:06 (OR = 19.1, 95% CI: 2.29–159, p = 0.005) and −G* 3′UTR 14‐bp insertion (OR = 2.17, 95% CI: 1.10–4.27, p = 0.020), whereas, the heterozygotic form of the G*01:01:01 wild‐type allele was significantly associated with a reduced risk of invasive cancer (OR = 0.31, 95% CI: 0.16–0.59, p < 0.0001) after adjusting for age, HPV infection and ethnicity. These associations were also observed with progression of disease from HG‐CIN to invasive cancer among HPV‐positive women. These results suggest that HLA‐G polymorphism is an independent risk factor for the development of invasive cervical cancer.

1 April 2011 in Human Immunology
Verified
Journal Article
Closed access
RFRhea Ferguson
Rhea Ferguson
ARAgnihotram V. Ramanakumar
Agnihotram V. Ramanakumar
HRHarriet Richardson
Harriet Richardson
PTPierre-Paul Tellier
Pierre-Paul Tellier
FCFrançois Coutlée
François Coutlée
MRMichel Roger
Michel Roger

11 December 2012 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
JPJohanne Poudrier
Johanne Poudrier
VTValérie Thibodeau
Valérie Thibodeau
MRMichel Roger
Michel Roger
Understanding how the mucosal immune system in the human female reproductive tract might prevent or facilitate HIV infection has important implications for the design of effective interventions. We and others have established cohorts of highly-exposed, HIV-seronegative individuals, such as HIV-uninfected commercial sex workers, who have remained HIV-negative after more than 5 years of active prostitution. Observations obtained in studies of such individuals, who represent a model of natural immunity to HIV, indicate that HIV resistance may be associated with the host’s capacity to preserve systemic integrity by constraining immune activity and controlling inflammatory conditions at the mucosal point of entry. This likely necessitates the orchestration of balanced, first-line and adaptive immune responses.

8 July 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JCJosiane Chagnon-Choquet
Josiane Chagnon-Choquet
JFJulie Fontaine
Julie Fontaine
JPJohanne Poudrier
Johanne Poudrier
MRMichel Roger
Michel Roger
FGfor the Montreal Primary HIV Infection and Slow Progressor Study Groups
for the Montreal Primary HIV Infection and Slow Progressor Study Groups
Understanding how the immune system facilitates or controls HIV-1 disease progression has important implications for the design of effective interventions. We report that although B-cell dysregulations associated with HIV-1 disease progression are accompanied by an overall decrease in the percentage of total blood B-cells, we observe an increase in relative frequencies of cells presenting characteristics of both transitional immature and first-line marginal zone (MZ) B-cell populations, we designated as precursor MZ-like B-cells. B-cells with similar attributes have been associated with IL-10 expression and “regulatory” potential. As such, the relative frequencies of precursor MZ-like B-cells expressing IL-10 are increased in the blood of viremic HIV-1-infected individuals when compared to HIV-negative subjects. Importantly, in aviremic HIV-1 Elite-Controllers (EC), we found unaltered relative percentages of precursor MZ-like B-cells which presented normal IL-10 expression patterns. Furthermore, EC had increased relative frequencies of blood MZ-like B-cells expressing LT-α. Thus in contrast to viremic HIV-1-infected individuals, EC present MZ-like B-cell populations which IL-10 and LT-α expression profiles may favour homeostasis of immune responses and lymphoid microenvironments.